一个结合了息预后指数和实验室预后得分的综合评分系统
Norihiro Yuasa1,2, Natsuko Kawai1, Junichi Takamizawa2
1Department of Palliative Medicine, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
The American journal of hospice & palliative care
|November 15, 2025
概括
将息预后指数 (PPI) 和实验室预后得分 (LPS) 结合起来,可以改善绝症癌症患者的生存预测. 新的PPI-LPS评分为息护理机构提供了一个简单而准确的工具.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 生物统计学 生物统计学
背景情况:
- 准确的生存预测对于绝症癌症患者至关重要.
- 现有的预后工具,如息预后指数 (PPI) 和实验室预后得分 (LPS) 有局限性.
- 结合临床和实验室数据可以提高预后准确性.
研究的目的:
- 评估综合息性预后指数-实验室预后得分 (PPI-LPS) 的预后性能.
- 将PPI-LPS得分与PPI,LPS和息预后得分 (PaP) 进行比较.
- 评估PPI-LPS得分对预测死亡率和生存时间的有用性.
主要方法:
- 综合PPI-LPS得分是通过平均PPI和LPS值来计算的.
- 分析了1061名急性护理息病房的绝症癌症患者.
- 预后性能通过对30日,60日和90日死亡率的歧视,中位数生存预测准确度和分类生存分类来评估.
主要成果:
- PPI-LPS得分显示了30日,60日和90日死亡率 (74%,80%,80%准确率) 的最高分辨能力.
- 它在预测中位生存率 (34%) 和分类生存率 (61%的同意) 中取得了卓越的准确性.
- 在所有预后评估中,综合得分优于个人得分 (PPI,LPS,PaP).
结论:
- 与现有工具相比,PPI-LPS结合得分提供了优越的预后性能.
- 这种简单,临床上有用的工具可以帮助在息治疗中估计存活率.
- PPI-LPS得分提高了绝症癌症患者的预后准确度.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
478
07:12Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Published on: July 7, 2016
20.9K
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Kaplan-Meier Approach
547
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
